Matthias Tschöp academisch docent
Tschöp, Matthias 1967-
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 20535115 (Personal)
Permalink: http://viaf.org/viaf/20535115
Preferred Forms
4xx's: Alternate Name Forms (5)
5xx's: Related Names (1)
Works
| Title | Sources |
|---|---|
| Etablierung und Anwendung einer nicht-isotopischen Methode für die Messung von Testosteron im Speichel |
|
| Global gene regulation during T cell activation |
|
| Globale Genregulation während der T-Zell-Aktivierung |
|
| The hypothalamic neural-glial network and the metabolic syndrome |
|
| Immunomodulation of metabolic tissue homeostasis |
|
| Influence of acute exposure to high altitude on basal and postprandial plasma levels of gastroenteropancreatic peptides |
|
| Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer |
|
| The insulin-like growth factor I receptor regulates glucose transport by astrocytes. |
|
| The intestinal lymph fistula model--a novel approach to study ghrelin secretion |
|
| Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5 |
|
| Isoenergetic feeding of low carbohydrate-high fat diets does not increase brown adipose tissue thermogenic capacity in rats |
|
| kappa-Opioid receptors control the metabolic response to a high-energy diet in mice |
|
| KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity |
|
| Leptin signaling in astrocytes regulates hypothalamic neuronal circuits and feeding |
|
| The Leptin System: A Potential Target for Sepsis Induced Immune Suppression |
|
| Lipoprotein lipase in hypothalamus is a key regulator of body weight gain and glucose homeostasis in mice |
|
| Long-Term Cold Adaptation Does Not Require FGF21 or UCP1. |
|
| Low-carbohydrate high-fat diets: regulation of energy balance and body weight regain in rats |
|
| The many faces of ghrelin: new perspectives for nutrition research? |
|
| MC4R dimerization in the paraventricular nucleus and GHSR/MC3R heterodimerization in the arcuate nucleus: is there relevance for body weight regulation? |
|
| Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity |
|
| Melanocortin signaling in the CNS directly regulates circulating cholesterol |
|
| Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes |
|
| Metabolic control by S6 kinases depends on dietary lipids |
|
| Metabolic Precision Medicines: Curing POMC Deficiency. |
|
| Metabolomic linkage reveals functional interaction between glucose-dependent insulinotropic polypeptide and ghrelin in humans |
|
| Mice lacking δ-opioid receptors resist the development of diet-induced obesity |
|
| Mice with chronically increased circulating ghrelin develop age-related glucose intolerance |
|
| Microvascular dysfunction in the course of metabolic syndrome induced by high-fat diet |
|
| miR-184 Regulates Pancreatic β-Cell Function According to Glucose Metabolism |
|
| Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and Obesity |
|
| Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice |
|
| Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors |
|
| N-acyl Taurines and Acylcarnitines Cause an Imbalance in Insulin Synthesis and Secretion Provoking β Cell Dysfunction in Type 2 Diabetes |
|
| Negative relationship between fasting plasma ghrelin concentrations and ad libitum food intake. |
|
| Neural regulation of cholesterol metabolism |
|
| Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity |
|
| NO to obesity: does nitric oxide regulate fat oxidation and insulin sensitivity? |
|
| Nutropioids, hedonism in the gut? |
|
| Obesity and the neuroendocrine control of energy homeostasis: the role of spontaneous locomotor activity |
|
| Obesity is associated with hypothalamic injury in rodents and humans |
|
| Obesity: will withaferin win the war? |
|
| Open housing drives the expression of immune response genes in the nasal mucosa, but not the olfactory bulb |
|
| Opposing Effects of Antidiabetic Interventions on Malignant Growth and Metastasis |
|
| Optimization of co-agonism at GLP-1 and glucagon receptors to safely maximize weight reduction in DIO-rodents |
|
| Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice |
|
| Outstanding Scientific Achievement Award Lecture 2011: defeating diabesity: the case for personalized combinatorial therapies |
|
| Overview of rodent models for obesity research. |
|
| p53 in AgRP neurons is required for protection against diet-induced obesity via JNK1 |
|
| p62 links β-adrenergic input to mitochondrial function and thermogenesis |
|
| Peptide lipidation stabilizes structure to enhance biological function |
|
| Peptide YY regulates bone turnover in rodents. |
|
| Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats |
|
| Peripheral ghrelin enhances sweet taste food consumption and preference, regardless of its caloric content |
|
| The pharmacokinetics of acyl, des-acyl, and total ghrelin in healthy human subjects |
|
| Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity |
|
| Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans |
|
| Pirt deficiency has subtle female-specific effects on energy and glucose metabolism in mice |
|
| PKCzeta-regulated inflammation in the nonhematopoietic compartment is critical for obesity-induced glucose intolerance |
|
| Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels |
|
| Play down protein to play up metabolism? |
|
| Post-transcriptional regulation by RNA-binding proteins in CD4+ T helper cells |
|
| Postprandial lysophospholipid suppresses hepatic fatty acid oxidation: the molecular link between group 1B phospholipase A2 and diet-induced obesity |
|
| Publisher Correction: Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes |
|
| Reappraisal of GIP Pharmacology for Metabolic Diseases |
|
| Renaissance of leptin for obesity therapy |
|
| Ring Finger Protein 11 Inhibits Melanocortin 3 and 4 Receptor Signaling |
|
| Role of adipose and hepatic atypical protein kinase C lambda (PKCλ) in the development of obesity and glucose intolerance |
|
| Role of astrocytes, microglia, and tanycytes in brain control of systemic metabolism |
|
| The role of ghrelin in the control of energy balance |
|
| Role of ghrelin polymorphisms in obesity based on three different studies. |
|
| role of mitochondrial fission protein Drp1 in pancreatic islets and beta cells |
|
| Rolle des mitochondrialen Fragmentierungsproteins Drp1 in pankreatischen Inseln und Betazellen |
|
| Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats |
|
| S6K1 controls pancreatic β cell size independently of intrauterine growth restriction |
|
| sabbu |
|
| Sans. |
|
| The scaffold protein p62 regulates adaptive thermogenesis through ATF2 nuclear target activation |
|
| Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure |
|
| Single-Molecule Combinatorial Therapeutics for Treating Obesity and Diabetes. |
|
| Sirt1 protects against high-fat diet-induced metabolic damage |
|
| Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity |
|
| Spare mitochondrial respiratory capacity permits human adipocytes to maintain ATP homeostasis under hypoglycemic conditions. |
|
| Streptozotocin-induced β-cell damage, high fat diet, and metformin administration regulate Hes3 expression in the adult mouse brain |
|
| The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes. |
|
| Synaptic plasticity in neuronal circuits regulating energy balance |
|
| Targeted estrogen delivery reverses the metabolic syndrome |
|
| Targeted pharmacological therapy restores β-cell function for diabetes remission |
|
| Testosterone replacement therapy restores normal ghrelin in hypogonadal men. |
|
| Therapeutic Potential of Targeting the Ghrelin Pathway |
|
| Time-resolved hypothalamic open flow micro-perfusion reveals normal leptin transport across the blood-brain barrier in leptin resistant mice. |
|
| TNFα drives mitochondrial stress in POMC neurons in obesity |
|
| Treatment of Diabetes and Obesity by Rationally Designed Peptide Agonists Functioning at Multiple Metabolic Receptors |
|
| Triglyceride-sensing in the mesocorticolimbic system and reward-driven behaviour control |
|
| The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV 21947) reduces body weight and plasma triglycerides in rodent models of diet-induced obesity |
|
| Twice the benefits with twincretins? |
|
